PeptideStack
5.2kquestions
20kanswers
220users

How does MKM compare to Qingdao Saber Technology on documentation quality?

Asked 19 May 2025Modified 11 months agoViewed 34k times
23

What I have: MKM · Qingdao Saber Technology.

The comparison I want does not seem to exist anywhere in a form I can evaluate.

I have read the arguments for each and they do not engage with each other.

What does each option buy me, and what does it cost me?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
shareeditfollowflag
ZA
askedzeynep_arslan16k2619 May 2025
4Voting to keep this open — it is more specific than it first looks. – bac_or_bust 3 months ago
add a comment

5 Answers

Accepted answer first, then by votes
15

Accepted answer

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Cost per milligram, adjusted honestly

StepValueNote
Vial price, 10 mg nominal£34.00As advertised
Nominal cost per mg£3.4034 ÷ 10
Measured content9.2 mgIndependent content assay
Cost per actual mg£3.7034 ÷ 9.2
Dead-space loss, 20 draws4 %80 µL of a 2 mL fill
Cost per delivered mg£3.853.70 ÷ 0.96
First vial, with £110 assay£14.85Testing dominates a single vial

The part that matters: lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
JW
answered · acceptedj_wierzbicki69k14825 Aug 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
28

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Worth being precise here: cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Price per milligram of measured peptide, not per milligram of label claim.

shareimprove this answerflag
TM
answeredtobias_maartens171k35811 Jun 2025
6

Worth being precise here: this is the question where methodology matters more than the conclusion.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Use a fixed documentation checklist rather than an impression.

edited 26 Aug 2025 by tobias_maartens — added a caveat about sampling

shareimprove this answerflag
TM
answeredtobias_maartens171k35814 Aug 2025
2

A single member running three suppliers on one method is worth more than thirty members running one supplier each.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
NK
answerednadia_kowalczyk20k2823 Jul 2025
The cost-per-milligram-of-measured-content correction reversed my own spreadsheet. – esther_vandeVelde 6 months ago
8This should be linked from the help pages. – Dr_Ilse_Vandenberg 5 months ago
add a comment
2

Put another way, ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Name the laboratory and the dates or the comparison cannot be reproduced.

shareimprove this answerflag
AH
answeredanja_hellstrom13k273 Aug 2025
3Adding for future readers: ask for the lot-specific certificate before ordering, not after. – p_mkhize 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.